review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-2478(97)00073-4 |
P698 | PubMed publication ID | 9232454 |
P50 | author | Hidde Ploegh | Q1617296 |
Domenico Tortorella | Q28051300 | ||
P2093 | author name string | Hill A | |
Wiertz E | |||
P2860 | cites work | Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction | Q24324602 |
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP | Q28239972 | ||
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol | Q29618773 | ||
A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface | Q33886108 | ||
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains | Q34063490 | ||
Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome | Q36027129 | ||
The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains | Q36398843 | ||
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process | Q37306358 | ||
Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport | Q39871967 | ||
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells | Q41116878 | ||
A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments | Q41141001 | ||
Herpes simplex virus turns off the TAP to evade host immunity | Q41338579 | ||
Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment | Q41606905 | ||
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. | Q42652565 | ||
Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase | Q45348443 | ||
A viral inhibitor of peptide transporters for antigen presentation | Q46243412 | ||
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. | Q53969958 | ||
Reversal of fortune for nascent proteins | Q59072797 | ||
Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product | Q59098221 | ||
Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance | Q64380296 | ||
An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens | Q64380351 | ||
Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1 | Q71739682 | ||
P433 | issue | 1-3 | |
P1104 | number of pages | 4 | |
P304 | page(s) | 213-216 | |
P577 | publication date | 1997-06-01 | |
P1433 | published in | immunology Letters | Q15766068 |
P1476 | title | Cytomegaloviruses use multiple mechanisms to elude the host immune response | |
P478 | volume | 57 |
Q42952042 | A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition |
Q33870381 | Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs |
Q77845857 | Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region |
Q78471193 | Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance |
Q27488053 | Cellular versus viral microRNAs in host-virus interaction |
Q24632103 | Consensus on the role of human cytomegalovirus in glioblastoma |
Q36224687 | Cyclic RNA hsa‑circ‑000595 regulates apoptosis of aortic smooth muscle cells |
Q46675725 | Cytomegalovirus M43 gene modulates T helper cell response |
Q34070154 | Cytomegalovirus bacterial artificial chromosomes: a new herpesvirus vector approach |
Q35005560 | Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development |
Q33812288 | Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs |
Q33927772 | Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection |
Q39595303 | Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression |
Q37949710 | Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis |
Q33843590 | Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65). |
Q37149865 | Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV) |
Q36529008 | Functional signatures of protective antiviral T-cell immunity in human virus infections. |
Q37073103 | Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo |
Q35099535 | How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance |
Q35994997 | Human herpes simplex virus keratitis: the pathogenesis revisited |
Q22008750 | Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis |
Q37805181 | Is HCMV a tumor promoter? |
Q36296307 | KIR-HLA intercourse in HIV disease |
Q89721556 | MicroRNA profiling in the bursae of Marek's disease virus-infected resistant and susceptible chicken lines |
Q33847137 | Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. |
Q38041963 | Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions |
Q33683408 | Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses |
Q34339686 | Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions |
Q43553165 | Prophylactic antiviral therapy in CMV high-risk liver transplant recipients |
Q58381844 | Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus |
Q52313512 | Recasting Human Vδ1 Lymphocytes in an Adaptive Role. |
Q81615839 | Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector |
Q36986555 | Targeted degradation of ABC transporters in health and disease. |
Q41776844 | The SCHOOL of nature: IV. Learning from viruses |
Q33797324 | The effect of viruses on the ability to present antigens via the major histocompatibility complex |
Q37383103 | The endoplasmic reticulum crossroads for newly synthesized polypeptide chains |
Q33883093 | The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. |
Q33697113 | The pathogenicity of cytomegalovirus |
Q39521419 | The polymorphic HCMV glycoprotein UL20 is targeted for lysosomal degradation by multiple cytoplasmic dileucine motifs. |
Q28214433 | The transporter associated with antigen processing: function and implications in human diseases |
Q38746541 | Transcriptome altered by latent human cytomegalovirus infection on THP-1 cells using RNA-seq |
Q34327234 | Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype |
Q24292060 | Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus |
Q37344402 | Viral pathogenesis, modulation of immune receptor signaling and treatment |
Q33668769 | Virus-encoded modulators of cytokines and growth factors |
Q24813634 | Virus-host interactions: new insights from the small RNA world. |